Interleukin (IL)-6, produced by vascular endothelial cells and TAMs, has been implicated in several pro-tumoral processes in GBM: (1) it contributes to the disruption of the BBB by downregulating intercellular tight junction proteins on endothelial cells (45). This evidence concerns the gene IL6 and glioblastoma.